Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Iterum Therapeutics logo

Iterum Therapeutics

Recent Finacing

Series B

Recent Raise

$65M

Iterum Therapeutics is a Dublin-based clinical-stage pharmaceutical company developing sulopenem, an oral and intravenous penem antibiotic with broad-spectrum activity against multidrug-resistant Gram-negative pathogens for UTI and intra-abdominal infections.

Founded 2015
Dublin, Ireland
11-50
Publicly Traded
iterumtx.com

Highlights

Focus Areas

Medical
Pharmaceutical
Therapeutics

Recent Investors

New Leaf Venture Partners logo
Frazier Healthcare Partners logo
Canaan Partners logo
Sofinnova Ventures logo
Advent Life Sciences logo
Domain Associates logo
Bay City Capital logo
Arix Bioscience logo
Pivotal bioVenture Partners logo

Financials

$105M

Total Raised

2

Funding rounds

9

Investors